SEER ProgramEffect Modifier, EpidemiologicSurvival AnalysisSurvival RateLife TablesKaplan-Meier EstimatePrognosisProportional Hazards ModelsCarcinoma, Pancreatic DuctalNeoplasm StagingAdenocarcinomaCell SurvivalAge FactorsDisease-Free SurvivalFollow-Up StudiesSurvivalGraft SurvivalTreatment OutcomeTime FactorsRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsLung NeoplasmsCombined Modality TherapyAntineoplastic AgentsCisplatinBrain NeoplasmsNeoplasm Recurrence, LocalLiver NeoplasmsNeoplasm MetastasisCarcinoma, Non-Small-Cell LungTumor Markers, BiologicalMultivariate AnalysisFluorouracilImmunohistochemistryDisease ProgressionApoptosisDrug Administration ScheduleBreast NeoplasmsCell Line, TumorDeoxycytidineMice, Inbred C57BLGlioblastomaCarcinoma, HepatocellularStomach NeoplasmsDoxorubicinColorectal NeoplasmsProspective StudiesCyclophosphamidePancreatic NeoplasmsMice, Inbred BALB CRisk FactorsLymphatic MetastasisAntimetabolites, AntineoplasticCarcinoma, Squamous CellDisease Models, AnimalChemotherapy, AdjuvantCohort StudiesGliomaGraft RejectionTransplantation, HomologousCarcinomaPaclitaxelOvarian NeoplasmsNeoplasm TransplantationPalliative CareSignal TransductionVincristineCell ProliferationPredictive Value of TestsGene Expression Regulation, NeoplasticNimustineDose-Response Relationship, DrugEtoposideBile Duct NeoplasmsRemission InductionCarcinoma, Small CellSkin TransplantationNeoplasmsNeoplasm InvasivenessMelanomaLeucovorinCamptothecinCarboplatinCholangiocarcinomaRecurrenceEsophageal NeoplasmsAntibodies, MonoclonalSupratentorial NeoplasmsRisk AssessmentInfusions, IntravenousDacarbazineOrganoplatinum CompoundsRadiotherapy, AdjuvantRadiotherapy DosageAntineoplastic Agents, PhytogenicMutationHeart TransplantationChemoembolization, TherapeuticBone NeoplasmsRegistries